Rubber stoppers are placed onto filled vials of remdesivir at a Gilead manufacturing site in the US in March.
Gilead last week received the US Food and Drug Administration’s emergency use authorisation for using remdesivir as a treatment against Covid-19, after the drugmaker provided data showing the drug had helped Covid-19 patients. One of Bangladesh’s largest drugmakers, Beximco Pharmaceuticals, will start remdesivir production this month, Reuters reported on Tuesday, citing a senior company executive.
Gilead, which has already said it will donate the first 1.5 million doses of remdesivir, also previously said it was focused on making the drug accessible and affordable to as many people as possible upon approval.
Just remember folks, this is the same company that brought you all the fraudulent Tamiflu vaccine.